BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 31790040)

  • 1. Providing Optimal Rejuvenation to the Periocular Area Using Botulinum Toxin A Neuromodulators and Hyaluronic Acid Dermal Fillers.
    Varga R
    Plast Surg Nurs; 2019; 39(4):119-124. PubMed ID: 31790040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Providing Optimal Rejuvenation to the Jawline and Perioral Area Using Neuromodulators and Hyaluronic Acid Dermal Fillers.
    Varga R
    Plast Surg Nurs; 2021 Apr-Jun 01; 41(2):98-104. PubMed ID: 34033635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsurgical periocular rejuvenation: advanced cosmetic uses of neuromodulators and fillers.
    Pao KY; Mancini R
    Curr Opin Ophthalmol; 2014 Sep; 25(5):461-9. PubMed ID: 24926573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rejuvenation of the Upper Face and Brow: Neuromodulators and Fillers.
    Lighthall JG
    Facial Plast Surg; 2018 Apr; 34(2):119-127. PubMed ID: 29631280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Aging Face: Global Approach With Fillers and Neuromodulators.
    Solish N
    Semin Cutan Med Surg; 2016 Jun; 35(6 Suppl):S120-1. PubMed ID: 27537350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Providing Optimal Rejuvenation to the Jawline and Perioral Area Using Neuromodulators and Hyaluronic Acid Dermal Fillers.
    Varga R
    Plast Surg Nurs; 2021 Oct-Dec 01; 41(4):225-231. PubMed ID: 34871290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler.
    Molina B; David M; Jain R; Amselem M; Ruiz-Rodriguez R; Ma MY; Kerrouche N; Georgantopoulos SP; Radeau T; Boineau D
    Dermatol Surg; 2015 Dec; 41 Suppl 1():S325-32. PubMed ID: 26618460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facial Contouring With Fillers, Neuromodulators, and Lipolysis to Achieve a Natural Look in Patients With Facial Fullness.
    Anand C
    J Drugs Dermatol; 2016 Dec; 15(12):1536-1542. PubMed ID: 28095576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Upper Face.
    de Maio M; Swift A; Signorini M; Fagien S;
    Plast Reconstr Surg; 2017 Aug; 140(2):265e-276e. PubMed ID: 28746271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant Use of Hyaluronic Acid and Laser in Facial Rejuvenation.
    Urdiales-Gálvez F; Martín-Sánchez S; Maíz-Jiménez M; Castellano-Miralla A; Lionetti-Leone L
    Aesthetic Plast Surg; 2019 Aug; 43(4):1061-1070. PubMed ID: 31073742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective and Safe Repeated Full-Face Treatments With AbobotulinumtoxinA, Hyaluronic Acid Filler, and Skin Boosting Hyaluronic Acid.
    Hedén P; Hexsel D; Cartier H; Bergentz P; Delmar H; Camozzato F; Siega C; Skoglund C; Edwartz C; Norberg M; Kestemont P
    J Drugs Dermatol; 2019 Jul; 18(7):682-689. PubMed ID: 31334927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Lower Face.
    de Maio M; Wu WTL; Goodman GJ; Monheit G;
    Plast Reconstr Surg; 2017 Sep; 140(3):393e-404e. PubMed ID: 28841604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A-Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations.
    Sundaram H; Liew S; Signorini M; Vieira Braz A; Fagien S; Swift A; De Boulle KL; Raspaldo H; Trindade de Almeida AR; Monheit G;
    Plast Reconstr Surg; 2016 May; 137(5):1410-1423. PubMed ID: 27119917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus Recommendations for Combined Aesthetic Interventions in the Face Using Botulinum Toxin, Fillers, and Energy-Based Devices.
    Carruthers J; Burgess C; Day D; Fabi SG; Goldie K; Kerscher M; Nikolis A; Pavicic T; Rho NK; Rzany B; Sattler G; Sattler S; Seo K; Werschler WP; Carruthers A
    Dermatol Surg; 2016 May; 42(5):586-97. PubMed ID: 27100962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies--consensus recommendations.
    Carruthers JDA; Glogau RG; Blitzer A;
    Plast Reconstr Surg; 2008 May; 121(5 Suppl):5S-30S. PubMed ID: 18449026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyaluronic acid rheology: Basics and clinical applications in facial rejuvenation].
    Billon R; Hersant B; Meningaud JP
    Ann Chir Plast Esthet; 2017 Jun; 62(3):261-267. PubMed ID: 28069316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts in lip augmentation.
    Mannino GN; Lipner SR
    Cutis; 2016 Nov; 98(5):325-329. PubMed ID: 28040807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical skin therapies in subjects undergoing full facial rejuvenation.
    Dayan SH; Bacos JT; Ho TT; Gandhi ND; Gutierrez-Borst S; Kalbag A
    J Cosmet Dermatol; 2019 Jun; 18(3):798-805. PubMed ID: 31033162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation.
    Carruthers A; Carruthers J; Monheit GD; Davis PG; Tardie G
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global, 3-dimensional approach to natural rejuvenation: part 1 - recommendations for volume restoration and the periocular area.
    Raspaldo H; Gassia V; Niforos FR; Michaud T
    J Cosmet Dermatol; 2012 Dec; 11(4):279-89. PubMed ID: 23174051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.